SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049071
Filing Date
2024-04-26
Accepted
2024-04-26 16:02:17
Documents
5
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A 2024_def_14a_ars.htm DEF 14A 647020
2 GRAPHIC img183538248_0.jpg GRAPHIC 6112
3 GRAPHIC img183538248_1.jpg GRAPHIC 6112
4 GRAPHIC img183538248_2.jpg GRAPHIC 275133
5 GRAPHIC img183538248_3.jpg GRAPHIC 134908
  Complete submission text file 0000950170-24-049071.txt   1230108
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Filer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39756 | Film No.: 24883423
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)